Andrew Hantel, MD

Medical Oncology

Andrew Hantel, MD

Andrew Hantel, MD is an Instructor in Medicine at Harvard Medical School and faculty member in the Divisions of Leukemia and Population Sciences at Dana-Farber Cancer Institute and the HMS Center for Bioethics. He received his MD from Loyola University Chicago; trained in internal medicine, adult hematology/oncology, and medical ethics at the University of Chicago; and completed a post-doctoral fellowship in cancer population sciences at the Dana-Farber/Harvard Cancer Center. Dr. Hantel's lab leverages health services and care delivery methods to address ethical dilemmas in cancer discovery and delivery. His current work focuses on equity in the contexts of research participation, artificial intelligence, and climate change.

View full profile

Related Videos

Andrew Hantel, MD Reviews Cancer Care and Greenhouse Gases Video

Andrew Hantel, MD Reviews Cancer Care and Greenhouse Gases

Telehealth can significantly reduce greenhouse gas emissions from cancer care, with research showing decentralized cancer care and telemedicine can cut emissions 33% compared to traditional in-person visits.

Andrew Hantel, MD, Discusses Artificial Intelligence Video

Andrew Hantel, MD, Discusses Artificial Intelligence

Artificial Intelligence in patient care - research presented at ASH23 by Dana-Farber's Andrew Hantel, MD, surveys oncologists about their feelings on incorporating AI into patient care.

Andrew Hantel, MD, Discusses Clinical Trial Disparities Video

Andrew Hantel, MD, Discusses Clinical Trial Disparities

At ASH23, Andrew Hantel, MD, Dana-Farber, presented his real-time interactive dashboard, which will help identify racial disparities in clinical trial enrollment for acute leukemia patients.